Compare IGR & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | IGR | UROY |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance Companies | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 645.2M | 601.8M |
| IPO Year | N/A | N/A |
| Metric | IGR | UROY |
|---|---|---|
| Price | $4.54 | $3.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 709.7K | ★ 2.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 13.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $275.63 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1,584.46 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.20 | $1.43 |
| 52 Week High | $5.37 | $5.52 |
| Indicator | IGR | UROY |
|---|---|---|
| Relative Strength Index (RSI) | 29.41 | 42.24 |
| Support Level | $4.49 | $3.54 |
| Resistance Level | $5.04 | $4.02 |
| Average True Range (ATR) | 0.08 | 0.25 |
| MACD | -0.05 | -0.04 |
| Stochastic Oscillator | 0.99 | 29.56 |
CBRE Clarion Global Real Estate Income Fund is a United States-based diversified, closed-end management investment company. Its primary objective is high current income, and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities, which includes common stocks, preferred securities, warrants, and convertible securities issued by real estate companies, such as real estate investment trusts. Under normal market conditions, it invests in real estate equity securities of companies domiciled predominantly in developed countries.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.